These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3749811)
41. A comparative therapeutic trial of sucralfate and ranitidine in initial healing and relapse rate of duodenal ulcer. Agrawal BK; Prasad RN; Kumar P J Assoc Physicians India; 1990 Sep; 38 Suppl 1():720-2. PubMed ID: 2092028 [TBL] [Abstract][Full Text] [Related]
42. Smoking as a risk factor for duodenal ulcer relapse. RUDER Study Group. Breuer-Katschinski BD; Armstrong D; Goebell H; Arnold R; Classen M; Fischer M; Blum AL Z Gastroenterol; 1995 Sep; 33(9):509-12. PubMed ID: 8525653 [TBL] [Abstract][Full Text] [Related]
43. Ranitidine in the treatment of duodenal ulceration. Peden NR; Boyd EJ; Saunders JH; Wormsley KG Scand J Gastroenterol; 1981 Apr; 16(3):325-9. PubMed ID: 16435471 [TBL] [Abstract][Full Text] [Related]
44. Tripotassium dicitrate bismuthate and ranitidine in duodenal ulcer. Healing and influence on recurrence. Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Dal Monte PR; D'Imperio N; Mazzacca G; D'Arienzo A; Cheli R; Bovero E Scand J Gastroenterol; 1988 Dec; 23(10):1232-6. PubMed ID: 3074457 [TBL] [Abstract][Full Text] [Related]
45. Ranitidine in the maintenance therapy of gastro-duodenal ulcer disease: Polish open multicentre study. Gibiński K; Nowak A; Gabryelewicz A; Szałaj W; Hasik J; Klincewicz H; Butruk E; Kosecki P; Pokora J; Radwan P Hepatogastroenterology; 1984 Aug; 31(4):180-2. PubMed ID: 6090287 [TBL] [Abstract][Full Text] [Related]
46. A placebo-controlled investigation of duodenal ulcer recurrence after withdrawal of long-term treatment with ranitidine. Penston JG; Dixon JS; Boyd EJ; Wormsley KG Aliment Pharmacol Ther; 1993 Jun; 7(3):259-65. PubMed ID: 8364131 [TBL] [Abstract][Full Text] [Related]
47. Relapse rate of healed duodenal, prepyloric, and gastric ulcers treated either with sucralfate or cimetidine. Glise H; Carling L; Hallerbaeck B; Hallgren T; Kagevi I; Solhaug JH; Svedberg LE; Waehlby L Am J Med; 1987 Sep; 83(3B):105-9. PubMed ID: 3310625 [TBL] [Abstract][Full Text] [Related]
49. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer. Farley A; Lévesque D; Paré P; Thomson AB; Sherbaniuk R; Archambault A; Mahoney K Am J Gastroenterol; 1985 Sep; 80(9):665-8. PubMed ID: 3898818 [TBL] [Abstract][Full Text] [Related]
50. Double-blind comparison of the safety and efficacy of famotidine with ranitidine in patients with endoscopically diagnosed peptic ulcer. Sawant PD; Nanivadekar SA; Patel HD; Shroff CP; Oke VG; Jha RJ; Bowalekar SK; Navani SR; Raghu CN J Assoc Physicians India; 1990 Sep; 38 Suppl 1():723-6. PubMed ID: 2092029 [TBL] [Abstract][Full Text] [Related]
52. [Therapy of stomach ulcer with sucralfate and ranitidine. A multicenter double-blind study]. Blum AL; Bode JC; Domschke W; Feurle G; Hackenberg K; Hammer B; Hüttemann W; Kachel G; Kaess H; Manegold BC Dtsch Med Wochenschr; 1986 Dec; 111(50):1910-5. PubMed ID: 3536400 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing. Bianchi Porro G; Parente F; Sangaletti O Gut; 1990 Apr; 31(4):397-400. PubMed ID: 2186980 [TBL] [Abstract][Full Text] [Related]
54. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer. Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E Digestion; 1985; 32 Suppl 1():32-7. PubMed ID: 2866134 [TBL] [Abstract][Full Text] [Related]
55. Ranitidine in the treatment of peptic ulcer. Makalinao AU; Zaño FM Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992 [TBL] [Abstract][Full Text] [Related]
56. Review of peptic ulcer maintenance trials. Robinson M Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657 [TBL] [Abstract][Full Text] [Related]
57. A maintenance regimen of sucralfate 2 g at night for reduced relapse rate in duodenal ulcer disease. A one-year follow-up study. Marks IN; Girdwood AH; Newton KA; O'Keefe SJ; Marotta F; Lucke W Am J Med; 1989 Jun; 86(6A):136-40. PubMed ID: 2735328 [TBL] [Abstract][Full Text] [Related]
58. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial. Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953 [TBL] [Abstract][Full Text] [Related]
59. Medical treatment of peptic ulcers. Deveney CW; Deveney KE Surg Annu; 1985; 17():219-33. PubMed ID: 3883541 [TBL] [Abstract][Full Text] [Related]
60. Comparison of sucralfate and ranitidine in the treatment of duodenal ulcers. Garcia-Paredes J; Diaz Rubio M; Llenas F; Taxonera C; Pardo L Am J Med; 1991 Aug; 91(2A):64S-67S. PubMed ID: 1882906 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]